ArticleNature communications2025

FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma.

Michal Beffinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.